Skip to main content

ORIGINAL RESEARCH article

Front. Neural Circuits, 20 March 2012

Selective serotonergic excitation of callosal projection neurons


Daniel Avesar, Daniel Avesar1,2Allan T. Gulledge,* Allan T. Gulledge1,2*
  • 1Department of Physiology and Neurobiology, Dartmouth Medical School, Lebanon, NH, USA
  • 2Program in Experimental and Molecular Medicine, Dartmouth College, Hanover, NH 03755, USA

Serotonin (5-HT) acting as a neurotransmitter in the cerebral cortex is critical for cognitive function, yet how 5-HT regulates information processing in cortical circuits is not well understood. We tested the serotonergic responsiveness of layer 5 pyramidal neurons (L5PNs) in the mouse medial prefrontal cortex (mPFC), and found three distinct response types: long-lasting 5-HT1A (1A) receptor-dependent inhibitory responses (84% of L5PNs), 5-HT2A (2A) receptor-dependent excitatory responses (9%), and biphasic responses in which 2A-dependent excitation followed brief inhibition (5%). Relative to 5-HT-inhibited neurons, those excited by 5-HT had physiological properties characteristic of callosal/commissural (COM) neurons that project to the contralateral cortex. We tested whether serotonergic responses in cortical pyramidal neurons are correlated with their axonal projection pattern using retrograde fluorescent labeling of COM and corticopontine-projecting (CPn) neurons. 5-HT generated excitatory or biphasic responses in all 5-HT-responsive layer 5 COM neurons. Conversely, CPn neurons were universally inhibited by 5-HT. Serotonergic excitation of COM neurons was blocked by the 2A antagonist MDL 11939, while serotonergic inhibition of CPn neurons was blocked by the 1A antagonist WAY 100635, confirming a role for these two receptor subtypes in regulating pyramidal neuron activity. Selective serotonergic excitation of COM neurons was not layer-specific, as COM neurons in layer 2/3 were also selectively excited by 5-HT relative to their non-labeled pyramidal neuron neighbors. Because neocortical 2A receptors are implicated in the etiology and pathophysiology of schizophrenia, we propose that COM neurons may represent a novel cellular target for intervention in psychiatric disease.

Introduction

Serotonin (5-hydroxytryptamine, or 5-HT) is a cortical neurotransmitter implicated in schizophrenia (Geyer and Vollenweider, 2008; Meltzer et al., 2011) and other mental health disorders (Filip and Bader, 2009). Postsynaptic serotonergic signaling in cortical pyramidal neurons relies primarily on two G-protein coupled receptors, 5-HT1A (1A) and 5-HT2A (2A), that have opposing influences on neuronal excitability. While most pyramidal neurons are inhibited by 5-HT via 1A receptor activation (Araneda and Andrade, 1991; Beique et al., 2004, 2007; Zhang and Arsenault, 2005; Goodfellow et al., 2009; Zhong and Yan, 2011), a minority is functionally excited via 2A receptors (Araneda and Andrade, 1991; Beique et al., 2007). Cortical 2A receptors, which are enriched in the prefrontal cortex (Pazos et al., 1985; Weber and Andrade, 2010), are of intense clinical interest because they mediate the psychotropic effects of serotonergic hallucinogens (Willins and Meltzer, 1997), are implicated in the development and etiology of schizophrenia (Benekareddy et al., 2010), and are the preferred targets for atypical antipsychotics (Gonzalez-Maeso and Sealfon, 2009). However, despite their pharmacological significance, little is known about the functional role of 2A receptors in regulating the activity of cortical microcircuits.

Layer 5 pyramidal neurons (L5PNs), which provide the bulk of cortical output, have been classified into distinct subclasses based on their morphology, physiology, axonal projections, and genetic expression patterns (Arlotta et al., 2005; Molnar and Cheung, 2006; Morishima and Kawaguchi, 2006; Sugino et al., 2006; Molyneaux et al., 2007; Chen et al., 2008; Leone et al., 2008; Brown and Hestrin, 2009; Morishima et al., 2011; Oberlaender et al., 2011). Each L5PN subclass represents a unique component of the local cortical microcircuit, displaying highly selective synaptic connectivity that generates directional information flow through segregated and parallel cortical output channels (Morishima and Kawaguchi, 2006; Brown and Hestrin, 2009; Morishima et al., 2011; Otsuka and Kawaguchi, 2011). It has been hypothesized that serotonergic 2A-dependent excitation may be restricted to one or more L5PN subtypes (Spain, 1994; Weber and Andrade, 2010), thereby allowing 5-HT to selectively enhance cortical output to specific target structures. To test this hypothesis, we used retrograde labeling to identify subtypes of L5PNs in the mouse prefrontal cortex based on their axonal projection patterns (Morishima and Kawaguchi, 2006; Dembrow et al., 2010; Morishima et al., 2011). We report that 5-HT, via 2A receptor activation, selectively generates excitatory and biphasic responses in pyramidal neurons projecting to the contralateral cortex, while brainstem-projecting pyramidal neurons are inhibited by 5-HT through 1A receptors. The identification of a specific pyramidal neuron subpopulation selectively excited by 2A receptors enhances our conceptual framework regarding serotonergic regulation of cortical microcircuits, and suggests callosal-projection neurons may represent a novel cellular target for the treatment of schizophrenia and other psychiatric diseases.

Methods

Animals

Wild-type C57Bl/6J (3-weeks–8-months-old) and Thy-1-YFP line H (3–7-weeks-old; Jackson Laboratory; see Feng et al., 2000) mice were used in experiments according to methods approved by the Institutional Animal Care and Use Committee of Dartmouth College.

Retrograde Labeling

Subpopulations of pyramidal neurons were labeled based on their axonal projections using stereotaxic injections of fluorescent beads (Retrobeads from Lumafluor, Inc.; 700 nL of undiluted solution per injection) into the contralateral medial prefrontal cortex (mPFC) or the pons (see Figure 3) using age-appropriate coordinates (Paxinos and Franklin, 2004). Animals were anesthetized for surgery with an IP injection of 2,2,2-tribromoethanol (20 mg/Kg). Surgeries lasted approximately 45 min, after which animals were allowed to recover for 72 h before use in electrophysiological experiments. Locations of dye injections were confirmed in coronal sections of the mPFC or brainstem.

Slice Preparation

Animals were anesthetized with isoflurane and decapitated. Brains were quickly removed into ice-cold artificial cerebral spinal fluid (ACSF) containing, in mM, 125 NaCl, 25 NaHCO3, 3 KCl, and 1.25 NaH2PO4, 0.5 CaCl2, 6 MgCl2, 25 glucose, and saturated with 95% O2/5% CO2. Coronal brain slices (200 μm thick) containing the mPFC were cut using a Leica VT 1200 slicer and transferred to a storage chamber filled with ACSF in which CaCl2 was increased to 2 mM and MgCl2 was decreased to 1 mM. Slices were maintained at 35°C for approximately 1 h, then stored at room temperature for up to 8 h prior to use in experiments.

Electrophysiology

Slices were transferred to a recording chamber below an Olympus BX51WI microscope and continuously perfused with oxygenated ACSF at 35°C. Whole-cell current-clamp recordings of L5PNs were made with patch pipettes (∼5 MΩ) filled with, in mM, 135 K-gluconate, 2 NaCl, 2 MgCl2, 10 HEPES, 3 Na2ATP, and 0.3 NaGTP (pH 7.2 with KOH). In some experiments, biocytin (7.5 mg/mL) was added to the pipette solution to allow for post-hoc visualization and morphological analysis of the recorded neuron (see below). Data were acquired with AxographX software (AxographX Company) using a BVC-700 amplifier (Dagan Corporation) and an ITC-18 digitizer (HEKA Instruments). Membrane potentials were filtered at 5 kHz, sampled at 25 kHz, and corrected for the junction potential of 12 mV. Input resistance (RN) was determined from the slope of the linear portion of the steady-state voltage-current relationship established with a series of somatic current injections (generally −50 to +50 pA). The magnitude of “sag” rectification (indicative of HCN channels in pyramidal neuron dendrites; see Dembrow et al., 2010) was quantified using a hyperpolarizing current injection sufficient to generate a 20 mV peak hyperpolarization relative to the resting membrane potential. Sag was defined as the relative “rebound” (percent) from peak membrane potential hyperpolarization, as measured at steady-state. Serotonergic inhibition was quantified as the duration of cessation of action potential generation following 5-HT application (see below). 5-HT-induced excitation was quantified as the peak increase in action potential rate, relative to baseline, measured over a 5 s period occurring around the timing of peak spike frequency following 5-HT application.

Drugs and Drug Application

Patch-pipettes were filled with 5-HT (100 μM) dissolved in ACSF and connected to a Toohey Spritzer (Toohey Company). Pipettes were positioned near the soma (within 50 μm) of targeted pyramidal neurons, and 5-HT was briefly applied (1 or 10 s) at low-pressure (∼4 PSI). 10 s applications were used in initial experiments in unlabeled tissue, while 1 s applications were used in tissue labeled with retrograde tracers (to reduce the prolonged duration of serotonergic inhibitory responses; compare Figure 1D with Figure 5A). Antagonists for 1A (WAY 100635; Sigma) and 2A (MDL 11939; Tocris) receptors were bath applied for 5 min prior to measurements of 5-HT responsiveness. When used, antagonists for ionotropic glutamate (kynurenic acid, 4 mM; Sigma) and GABA (SR-95531, 10 μM; Sigma) receptors were bath applied for at least 5 min before experiments.

FIGURE 1
www.frontiersin.org

Figure 1. Diversity of serotonin responses in prefrontal layer 5 pyramidal neurons (L5PNs). (A–C) Responses to focal serotonin application (100 μM, 10 s, beginning at arrow) in L5PNs during periods of current-driven action potential generation. Three response types were observed: inhibition, blocked by the 1A antagonist WAY 100635 (A), excitation, blocked by the 2A antagonist MDL 11939 (B), and biphasic responses consisting of short-duration inhibition followed by excitation, also sensitive to the 2A antagonist (C). (D) Comparisons of the duration of inhibition (bottom) and peak changes in spike rate (top) according to serotonergic response type. (E) Proportions of L5PNs exhibiting different serotonin responses in neurons from the mPFCs of adolescent mice, fully adult mice, and adolescent Thy1-YFP mice in which a subpopulation of L5PNs are selectively labeled with yellow fluorescent protein (YFP).

Histology, Imaging, and Morphological Analysis

Slices containing biocytin-filled neurons were fixed in phosphate-buffered solution (PBS) containing 4% paraformaldehyde and 0.2% picric acid. After 24 h, slices were washed several times in PBS and incubated for up to 12 h in PBS containing 0.25% Triton X-100 and avidin conjugated to Alexa Fluor® 488 (20 μg/ml; Invitrogen). Slices were then dried, imbedded in FluorSave (EMD Chemicals), and imaged on a 2-photon microscope (Prairie Technologies). To compare neuron morphologies, we quantified somatic distance from the pia, maximum horizontal width of the apical tuft, the number of dendritic branch points in the tuft, and the number of primary oblique dendrites. Tracings of neurons were made using NeuronJ (freely available at http://www.imagescience.org/meijering/software/neuronj/) from z-stack projections (1 μm sections).

Statistical Analysis

Data are presented as mean ± SEM. Physiological measurements of membrane potential (VM), RN, and sag rectification in 5-HT-inhibited, -excited, and -biphasic neurons were compared using One-Way ANOVAs (with Tukey-Kramer post-tests) for each parameter. One-Way ANOVAs and post-tests were also used to compare the physiology of callosal projection (5-HT-excited and -biphasic) and pontine-projecting L5PNs. Other comparisons used a 2-tailed Student's t-test, paired or un-paired, as appropriate. Significance was defined as p < 0.05.

Results

Serotonergic Responses in Prefrontal Layer 5 Pyramidal Neurons

In initial experiments, we focally applied 5-HT (100 μM for 10 s) to L5PNs during periods of current-induced action potential generation in acute slices of unlabeled mPFC from 3–5-weeks-old mice (Figure 1 and Table 1). 5-HT inhibited action potential generation in 84% (145 of 172) of unlabeled L5PNs (Figures 1A,D,E), but increased action potential frequency in another 14% of L5PNs (24 of 172). Only a few L5PNs (3 of 172 neurons; 2%) were not responsive to 5-HT. Serotonergic excitation occurred either alone (9%; 15 of 172; Figures 1B,D,E), or as part of biphasic responses consisting of short-duration inhibition followed by longer-lasting excitation (5%; 9 of 172; Figures 1C,D,E). In agreement with previous studies (Puig et al., 2005; Benekareddy et al., 2010), we found serotonergic inhibition and excitation were blocked by antagonists specific for 1A receptors (WAY 100635, 30 nM; n = 16; Figure 1A) or 2A receptors (MDL 11939, 500 nM; n = 4; Figures 1B,C), respectively.

TABLE 1
www.frontiersin.org

Table 1. Physiology and serotonergic responsiveness of L5PN subpopulations.

In L5PNs, a well characterized developmental increase in 1A receptor expression induces a phenotypic “switch” from serotonergic excitation to serotonergic inhibition during the third postnatal week (Zhang, 2003; Beique et al., 2004). Although we used neurons from animals over 3 weeks of age, we confirmed our results did not reflect delayed maturation of L5PNs by conducting additional experiments using neurons from 7- to 8-month-old mice (n = 11) and from 3- to 7-week-old Thy-1 YFP line H mice (n = 34), in which a subpopulation of L5PNs is labeled with YFP. We found 5-HT to excite similar proportions of L5PNs (18% and 20%, respectively) in both groups (Figure 1E and Table 1).

Prefrontal L5PNs are heterogeneous in their physiological properties (Dembrow et al., 2010). To determine whether serotonergic responsiveness correlates with physiology, we compared resting VM, RN, and the amount of “sag” rectification occurring during hyperpolarizing current injections in 5-HT-excited and 5-HT-inhibited L5PNs (Figure 2 and Table 1). We found 5-HT-excited L5PNs had higher RN (100 ± 7 MΩ) and less sag (10 ± 1% sag) than did L5PNs inhibited by 5-HT (RN, and sag for inhibited L5PNs were 75 ± 2 MΩ and 16 ± 0%, respectively, p < 0.05 for each when compared to values from 5-HT-excited neurons). These results suggest 5-HT may selectively excite a physiologically distinct subpopulation of L5PNs.

FIGURE 2
www.frontiersin.org

Figure 2. Responsiveness to serotonin correlates with membrane physiology. (A) Top, voltage responses to somatic current injections (−50 to 50 pA in 5 pA steps) in unlabeled L5PNs. Bottom, comparison of input resistance (RN) in neurons having different responses to serotonin. (B) Average (± SEM) voltage responses to hyperpolarizing current injections sufficient to generate a peak hyperpolarization of ∼20 mV in unlabeled L5PNs grouped according to their responsiveness to serotonin (blue indicates serotonergic inhibition, red indicates serotonergic excitation, and orange indicates biphasic responses). Comparison of results is inset. Asterisks indicate p < 0.05.

Selective Serotonergic Excitation of Callosal/Commissural Projection Neurons

COM projection L5PNs connecting homologous cortical areas in the two cerebral hemispheres have relatively high RN and modest sag rectification, physiological properties similar to those found in 5-HT-excited L5PNs (Dembrow et al., 2010). To test whether COM neurons include those excited by 5-HT, we injected fluorescent Retrobeads unilaterally into the left mPFC and later recorded serotonergic responses in labeled COM neurons in slices of the contralateral cortex (Figure 3A). Focal 5-HT application (100 μM for 1 s) generated excitatory (n = 15) or biphasic (n = 9) responses in all 5-HT-responsive COM neurons (93%; 24 of 26 tested neurons; Figures 4A,C). Purely inhibitory responses were never observed in COM neurons. Serotonergic excitation of COM neurons was blocked by MDL 11939 (n = 5; Figure 4D), confirming a functional role for 2A receptors in regulating COM neuron excitability.

FIGURE 3
www.frontiersin.org

Figure 3. Retrograde labeling of prefrontal projection neurons. (A) Images of coronal sections of prefrontal cortex (top) or brainstem (bottom) showing locations of dye injection for retrograde labeling of callosal/commisseral (COM) and corticopontine (CPn) projection neurons. (B) Cartoons of retrograde labeling of COM (top) and CPn neurons (bottom). (C) Images of COM (top) and CPn (bottom) neurons that were filled with biocytin during recording and labeled with a fluorescent-conjugated avidin. The punctate Retrobead staining of other COM and CPn somata are visible in the backgrounds (white arrows point out examples).

FIGURE 4
www.frontiersin.org

Figure 4. Serotonin selectively excites commissural/callosal (COM) projection neurons. (A) Excitatory (left) and biphasic (right) responses to focal serotonin application in COM neurons. (B) Inhibitory response to serotonin in a corticopontine (CPn) neuron. (C) Proportion of COM and CPn neurons excited (red), inhibited (blue), or having biphasic (orange) responses to 5-HT. Non-responsive neurons (NR) shown in gray. (D) Serotonergic excitation of COM neurons (left) and inhibition of CPn neurons (right) was blocked by antagonists specific for 2A (MDL 11939) or 1A (WAY 100635) receptors, respectively.

We next applied 5-HT to a second, non-overlapping L5PN population projecting to the pons (CPn, see Dembrow et al., 2010) (Figure 3B). In contrast to COM neurons, all CPn neurons tested (n = 17) were inhibited by 5-HT (Figures 4B,C), and this inhibition was blocked by the 1A antagonist WAY 100635 (n = 4; Figure 4D). To confirm that selective serotonergic regulation of COM and CPn L5PNs does not result from indirect modulation of excitatory drive onto L5PNs, in additional experiments we measured serotonergic responses in the presence of blockers of fast synaptic transmission (4 mM kynurenic acid, to block ionotropic glutamate receptors, and 10 μM SR-95531, to block GABAA receptors; see Gulledge and Stuart, 2005). With fast synaptic transmission blocked, 5-HT selectively excited all COM neurons tested (n = 12), generating pure excitations (n = 7) or biphasic excitations (n = 5) indistinguishable from those generated in COM neurons in the absence of synaptic blockers (Figure 5). Similarly, in the presence of synaptic blockers, 5-HT inhibited all CPn neurons tested (n = 3) for durations comparable to those generated in the absence of blockers (Figure 5). These data demonstrate that selective regulation of COM and CPn neuron excitability by 5-HT does not depend on changes in fast synaptic transmission.

FIGURE 5
www.frontiersin.org

Figure 5. Serotonergic regulation of commissural/callosal (COM) and corticopontine (CPn) projection neurons does not require changes in fast synaptic transmission. (A) Comparisons of the duration of inhibition (bottom) and serotonin-induced changes in spike rate (top) in COM and CPn neurons in regular saline (solid bars) and in the presence of synaptic blockers (4 mM kynurenic acid, 10 μM SR 95531; striped bars). NS indicates non-significant differences between within-cell-type groups (unpaired Student's t-tests). Asterisks indicate p < 0.05 (One-Way ANOVAs). (B) Proportions of serotonergic responses in COM (top) and CPn neurons (bottom) recorded in the presence of 4 mM kynurenic acid and 10 μM SR-95531.

Physiology and Morphology of COM and CPn Neurons

In the rat mPFC, COM and CPn L5PNs have distinct physiological and morphological properties (Dembrow et al., 2010). To determine whether this is also the case in the mouse mPFC, we measured physiological parameters in COM and CPn neurons, and filled a subset of neurons with biocytin during recording for post-hoc analysis of morphologies (Figure 6). COM and CPn neurons were physiologically distinct, with COM neurons (n = 26) having more hyperpolarized resting membrane potentials (−81 ± 1 mV), higher >RN (144 ± 7 MΩ), and less sag rectification (6 ± 1%) than CPn neurons (mean VM, RN, and sag for CPn neurons were −76 ± 1 mV, 78 ± 4 MΩ, and 16 ± 1%, respectively; p < 0.05 for each; Figures 6A,B, and Table 1). COM neurons were also morphologically distinct from CPn neurons, having more superficial somata (somatic depths were 332 ± 18 μm vs. 405 ± 14 μm), more horizontally compact apical tufts (maximal tuft widths were 211 ± 30 μm vs. 302 ± 34 μm), and fewer basal (6.7 ± 0.7 vs. 9.2 ± 1.0), oblique (4.6 ± 0.7 vs. 13.3 ± 1.2), and tuft (4.0 ± 0.7 vs. 7.2 ± 0.7) dendritic branches, than CPn neurons (n = 10 for each group; p < 0.05 for each group, paired Student's t-tests; Figures 6C–H). Together, these data demonstrate selective and opposing serotonergic regulation of distinct L5PN subtypes in the mouse prefrontal cortex.

FIGURE 6
www.frontiersin.org

Figure 6. Physiological and morphological differences in commissural/callosal (COM) and corticopontine (CPn) projection neurons. (A) Top, responses to somatic current injections in retrograde-labeled COM and CPn neurons. Bottom, comparison of input resistance (RN) in neurons having different responsiveness to 5-HT. (B) Average (± SEM) voltage responses to hyperpolarizing current injections sufficient to generate a peak hyperpolarization of ∼20 mV in labeled COM and CPn neurons grouped according to serotonin response (blue indicates inhibition, red indicates excitation, and orange indicates biphasic responses). Comparison of results is inset. (C) Representative morphologies of COM and CPn neurons. (D–H) Comparisons of morphological properties in COM and CPn neurons (n = 10 for each group). Response type of the neuron is color-coded, as indicated. Asterisks indicate p < 0.05.

Selective Serotonergic Excitation of COM Neurons in Layer 2/3

In the mPFC, COM neuron somata are found in both layer 5 and layer 2/3 (Morishima and Kawaguchi, 2006). We focally applied 5-HT to COM-labeled and neighboring non-labeled layer 2/3 pyramidal neurons (L2/3PNs) to test whether selective serotonergic excitation of COM neurons is conserved across cortical lamina (Figure 7). Indeed, out of 21 COM-labeled L2/3PNs, 18 showed excitatory or biphasic responses. No COM L2/3PNs had purely inhibitory responses to 5-HT (3 COM L2/3PNs were not responsive to 5-HT). On the other hand, two-thirds of non-labeled L2/3PNs (n = 12 of 18) were inhibited by 5-HT, while another third (n = 6) exhibited excitatory responses. Physiological properties of COM and unlabeled L2/3PNs were, for the most part, similar and independent of their serotonergic responsiveness. The exception was the finding of a higher input resistance in COM L2/3PNs, relative to their unlabeled neighbors (Table 2). Together, these data demonstrate that selective excitation of COM neurons is not restricted to layer 5, but appears instead to be a common feature of prefrontal COM neurons.

FIGURE 7
www.frontiersin.org

Figure 7. Selective excitation of pyramidal neurons in layers 2/3 of the mPFC.(A) Excitatory response to 5-HT in a COM-labeled L2/3PN (voltage trace, above, and instantaneous spike frequency [ISF] plot, below). Dashed lines indicate zero Hz. (B) Serotonergic response in a “biphasic” COM L2/3PN. (C) Serotonergic inhibition of a non-labeled L2/3PN in tissue labeled for COM neurons. (D) Proportions of serotonergic responses in COM-labeled and neighboring non-labeled L2/3PNs.

TABLE 2
www.frontiersin.org

Table 2. Physiology and serotonergic responsiveness of L2/3PNs.

Discussion

We found that 5-HT selectively increases the excitability of COM neurons by activation of 2A receptors, while inhibiting output from the vast majority of cortical pyramidal neurons, including all CPn neurons, via 1A receptor activation. Because 2A receptors in the prefrontal cortex are implicated in the pathophysiology of schizophrenia (Willins and Meltzer, 1997; Gonzalez-Maeso and Sealfon, 2009; Benekareddy et al., 2010), our data suggest excessive activation of COM neurons, which provide the bulk of long-range intra- and inter-hemispheric cortico-cortical projections (Otsuka and Kawaguchi, 2011), may play a central role in psychosis. We, therefore, propose that COM neurons represent a novel cellular, rather than molecular, target for the treatment of psychiatric diseases involving dysregulation of 2A receptor signaling.

Selective Excitation of COM Neurons

We found three distinct responses to 5-HT in L5PNs from unlabeled tissue: 1A-mediated inhibition, 2A-mediated excitation, and biphasic responses resulting from coactivation of 1A and 2A receptors. 5-HT-excited L5PNs had physiological properties characteristic of COM neurons (Dembrow et al., 2010), and experiments targeting labeled COM neurons confirmed that this population is selectively excited by 5-HT via 2A receptors. On the other hand, 5-HT inhibited all labeled CPn neurons via 1A receptor activation. These data are significant in demonstrating, for the first time, selective serotonergic activation of a specific cortical output channel. 2A receptor-dependent serotonergic excitation of COM neurons may also explain the parallel rostral-to-caudal gradients found for cortical 2A receptor expression (Pazos et al., 1985; Weber and Andrade, 2010) and COM neuron density (Chao et al., 2009).

Two observations suggest that 5-HT may excite additional, non-COM L5PN populations. First, differences in membrane physiology were more exaggerated when comparing 5-HT-inhibited CPn neurons with excited and biphasic COM neurons than when comparing unlabeled L5PNs grouped according to their serotonergic response. For instance, CPn neurons were significantly more hyperpolarized than were COM neurons, but VM was not well correlated with serotonin responsiveness in unlabeled L5PNs (Table 1, compare also Figure 2B with Figure 6B). Second, biphasic and excited COM neurons exhibited physiological properties distinct from the populations of excited and biphasic neurons found in unlabeled tissue. For instance, COM neurons had higher RN values than did unlabeled L5PNs excited by 5-HT (Table 1).

It is possible that some of the physiological differences observed in labeled and unlabeled L5PNs reflect unintentional selection bias when visually choosing unlabeled neurons for whole-cell recording. For instance, the tendency to target larger, more prominent somata could contribute to the lower input resistances found in unlabeled 5-HT-excited neurons. Similarly, targeting of larger neurons in unlabeled tissue might bias selection toward L5PNs projecting toward the brainstem (Morishima and Kawaguchi, 2006; Dembrow et al., 2010), which may explain why only 15% of unlabeled L5PNs showed 2A-dependent excitation even while COM neurons, which were overwhelmingly excited by 5-HT, make up closer to 25% of all L5PNs (Hattox and Nelson, 2007). Alternatively, differences in the physiology of COM neurons and unlabeled 5-HT-excited L5PNs are consistent with the hypothesis that additional L5PN subpopulations are excited via 2A receptor activation. Additional studies will be needed to test serotonergic responsiveness of other L5PN projection subtypes, such as those projecting to the thalamus, the ventral tegmentum, and dorsal raphe. It will also be necessary to test whether selective serotonergic activation of COM neurons is conserved across species. For instance, Beique et al. (2007) found that “approximately one-third” of deep layer pyramidal neurons in the rat mPFC are excited by 2A receptor activation. Our results suggest that the 5-HT-excited subpopulation of pyramidal neurons in the rat cortex may include COM neurons. Such a finding would suggest that 2A-dependent excitation of COM neurons may be a conserved feature of the mammalian prefrontal cortex.

Role of Serotonin in Cortical Function and Pathology

The quest to identify a role of 5-HT in regulating cortical activity has been marked by the apparent paradox that pyramidal neurons express both inhibitory (1A) and excitatory (2A) receptors (Amargos-Bosch et al., 2004; Santana et al., 2004; Puig et al., 2010), yet the majority of adult pyramidal neurons are functionally inhibited by 5-HT (Araneda and Andrade, 1991; Beique et al., 2004; Zhang and Arsenault, 2005; Beique et al., 2007; Goodfellow et al., 2009; Zhong and Yan, 2011). 2A receptors expressed by non-COM neurons may have important roles independent of direct modulation of intrinsic membrane excitability. For instance, 2A receptors may regulate synaptic transmission and plasticity by influencing AMPA and NMDA receptor function (Yuen et al., 2008; Zhong et al., 2008a,b). Our data demonstrate 2A receptors selectively enhance action potential generation in COM neurons independent of synaptic input, but do not preclude the possibility that 2A receptors may also have effects on synaptic transmission in these neurons. Our finding opposing actions of 5-HT in COM and CPn neurons add to a growing body of evidence pointing to highly selective serotonergic modulation of cellular components within cortical microcircuits (Zhou and Hablitz, 1999; Foehring et al., 2002; Xiang and Prince, 2003; Amargos-Bosch et al., 2004; Puig et al., 2004; Kruglikov and Rudy, 2008; Lee et al., 2010).

How does selective activation of COM neurons facilitate information processing in the prefrontal cortex? COM neurons are synaptically coupled to each other, and provide unidirectional excitatory input to CPn neurons (Morishima and Kawaguchi, 2006), suggesting that serotonergic activation of COM neurons may increase glutamate release onto both COM and CPn neurons, while direct 1A-dependent inhibition of CPn output would have little impact on ongoing COM neuron activity. If 5-HT-excited neurons are reciprocally connected (Morishima et al., 2011), 5-HT could promote reverberatory excitation in small networks of interconnected COM neurons (see also Williams et al., 2002), whose collateral connections to other COM and CPn neurons might underly 2A-dependent increases in spontaneous excitatory synaptic transmission (Aghajanian and Marek, 1997; Zhou and Hablitz, 1999; Lambe et al., 2000; Beique et al., 2007). Concurrent serotonergic inhibition of CPn and other L5PN subtypes would further enhance the overall signal-to-noise of cortical output to the brainstem.

Serotonin also regulates the activity of cortical GABAergic interneurons (Zhou and Hablitz, 1999; Murakoshi et al., 2001; Foehring et al., 2002; Xiang and Prince, 2003; Weber and Andrade, 2010) and suppresses transmitter release from axon terminals (Tanaka and North, 1993; Zhou and Hablitz, 1999; Torres-Escalante et al., 2004; Kruglikov and Rudy, 2008; Troca-Marin and Geijo-Barrientos, 2010), both of which might selectively gate information flow in cortical microcircuits. For instance, ionotropic 5-HT3A receptors are expressed by most, if not all, layer 1 interneurons (Foehring et al., 2002; Weber and Andrade, 2010), where 5-HT3A-mediated excitation would be expected to enhance feed-forward inhibition of pyramidal neuron apical dendrites. Similarly, much as selective serotonergic regulation of pyramidal neuron excitability accounts for the heterogeneity of 5-HT responses reported in previous studies, selective control of transmitter release at synapses according to their pre- and postsynaptic identity may explain the diversity of effects of 5-HT on synaptic transmission (e.g., as in Troca-Marin and Geijo-Barrientos, 2010). Dedicated studies will be necessary to characterize selective serotonergic control of these other components of cortical microcircuits.

Finally, the precision with which 5-HT selectively regulates cortical output channels may explain why disruption of serotonergic signaling contributes to a wide variety of mental health disorders. In particular, excessive 2A receptor activation is implicated in the etiology of many psychiatric conditions, including depression, anxiety, and schizophrenia, while 2A antagonists are efficacious in treating these disorders (Naughton et al., 2000). The selective 2A-dependent excitation of COM neurons described here suggests these neurons may represent a novel cellular target for intervention in psychiatric disease.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

This work was supported by PHS grant R01 MH83806 (Allan T. Gulledge) and a NARSAD Young Investigator Award from the Brain and Behavior Research Foundation (Allan T. Gulledge). The authors thank Allie Rudkin, Pamela Yeh, and Alex Bender for technical assistance, Ken Orndorff for assistance with microscopy, and Sameera Dasari, Byran Luikart, and Vicky Puig for helpful comments on the manuscript.

References

Aghajanian, G. K., and Marek, G. J. (1997). Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology 36, 589–599.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Amargos-Bosch, M., Bortolozzi, A., Puig, M. V., Serrats, J., Adell, A., Celada, P., Toth, M., Mengod, G., and Artigas, F. (2004). Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex. Cereb. Cortex 14, 281–299.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Araneda, R., and Andrade, R. (1991). 5-Hydroxytryptamine2 and 5-hydroxytryptamine 1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience 40, 399–412.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Arlotta, P., Molyneaux, B. J., Chen, J., Inoue, J., Kominami, R., and Macklis, J. D. (2005). Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo. Neuron 45, 207–221.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Beique, J. C., Campbell, B., Perring, P., Hamblin, M. W., Walker, P., Mladenovic, L., and Andrade, R. (2004). Serotonergic regulation of membrane potential in developing rat prefrontal cortex: coordinated expression of 5-hydroxytryptamine (5-HT)1A, 5-HT2A, and 5-HT7 receptors. J. Neurosci. 24, 4807–4817.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Beique, J. C., Imad, M., Mladenovic, L., Gingrich, J. A., and Andrade, R. (2007). Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex. Proc. Natl. Acad. Sci. U.S.A. 104, 9870–9875.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Benekareddy, M., Goodfellow, N. M., Lambe, E. K., and Vaidya, V. A. (2010). Enhanced function of prefrontal serotonin 5-HT(2) receptors in a rat model of psychiatric vulnerability. J. Neurosci. 30, 12138–12150.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Brown, S. P., and Hestrin, S. (2009). Intracortical circuits of pyramidal neurons reflect their long-range axonal targets. Nature 457, 1133–1136.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Chao, Y. P., Cho, K. H., Yeh, C. H., Chou, K. H., Chen, J. H., and Lin, C. P. (2009). Probabilistic topography of human corpus callosum using cytoarchitectural parcellation and high angular resolution diffusion imaging tractography. Hum. Brain Mapp. 30, 3172–3187.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Chen, B., Wang, S. S., Hattox, A. M., Rayburn, H., Nelson, S. B., and Mcconnell, S. K. (2008). The Fezf2-Ctip2 genetic pathway regulates the fate choice of subcortical projection neurons in the developing cerebral cortex. Proc. Natl. Acad. Sci. U.S.A. 105, 11382–11387.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Dembrow, N. C., Chitwood, R. A., and Johnston, D. (2010). Projection-specific neuromodulation of medial prefrontal cortex neurons. J. Neurosci. 30, 16922–16937.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Feng, G., Mellor, R. H., Bernstein, M., Keller-Peck, C., Nguyen, Q. T., Wallace, M., Nerbonne, J. M., Lichtman, J. W., and Sanes, J. R. (2000). Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 28, 41–51.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Filip, M., and Bader, M. (2009). Overview on 5-HT receptors and their role in physiology and pathology of the central nervous system. Pharmacol. Rep. 61, 761–777.

Pubmed Abstract | Pubmed Full Text

Foehring, R. C., van Brederode, J. F., Kinney, G. A., and Spain, W. J. (2002). Serotonergic modulation of supragranular neurons in rat sensorimotor cortex. J. Neurosci. 22, 8238–8250.

Pubmed Abstract | Pubmed Full Text

Geyer, M. A., and Vollenweider, F. X. (2008). Serotonin research: contributions to understanding psychoses. Trends Pharmacol. Sci. 29, 445–453.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Gonzalez-Maeso, J., and Sealfon, S. C. (2009). Psychedelics and schizophrenia. Trends Neurosci. 32, 225–232.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Goodfellow, N. M., Benekareddy, M., Vaidya, V. A., and Lambe, E. K. (2009). Layer II/III of the prefrontal cortex: inhibition by the serotonin 5-HT1A receptor in development and stress. J. Neurosci. 29, 10094–10103.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Gulledge, A. T., and Stuart, G. J. (2005). Cholinergic inhibition of neocortical pyramidal neurons. J. Neurosci. 25, 10308–10320.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Hattox, A. M., and Nelson, S. B. (2007). Layer V neurons in mouse cortex projecting to different targets have distinct physiological properties. J. Neurophysiol. 98, 3330–3340.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Kruglikov, I., and Rudy, B. (2008). Perisomatic GABA release and thalamocortical integration onto neocortical excitatory cells are regulated by neuromodulators. Neuron 58, 911–924.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Lambe, E. K., Goldman-Rakic, P. S., and Aghajanian, G. K. (2000). Serotonin induces EPSCs preferentially in layer V pyramidal neurons of the frontal cortex in the rat. Cereb. Cortex 10, 974–980.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Lee, S., Hjerling-Leffler, J., Zagha, E., Fishell, G., and Rudy, B. (2010). The largest group of superficial neocortical GABAergic interneurons expresses ionotropic serotonin receptors. J. Neurosci. 30, 16796–16808.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Leone, D. P., Srinivasan, K., Chen, B., Alcamo, E., and Mcconnell, S. K. (2008). The determination of projection neuron identity in the developing cerebral cortex. Curr. Opin. Neurobiol. 18, 28–35.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Meltzer, H. Y., Horiguchi, M., and Massey, B. W. (2011). The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment. Psychopharmacology (Berl.) 213, 289–305.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Molnar, Z., and Cheung, A. F. (2006). Towards the classification of subpopulations of layer V pyramidal projection neurons. Neurosci. Res. 55, 105–115.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Molyneaux, B. J., Arlotta, P., Menezes, J. R., and Macklis, J. D. (2007). Neuronal subtype specification in the cerebral cortex. Nat. Rev. Neurosci. 8, 427–437.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Morishima, M., and Kawaguchi, Y. (2006). Recurrent connection patterns of corticostriatal pyramidal cells in frontal cortex. J. Neurosci. 26, 4394–4405.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Morishima, M., Morita, K., Kubota, Y., and Kawaguchi, Y. (2011). Highly differentiated projection-specific cortical subnetworks. J. Neurosci. 31, 10380–10391.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Murakoshi, T., Song, S. Y., Konishi, S., and Tanabe, T. (2001). Multiple G-protein-coupled receptors mediate presynaptic inhibition at single excitatory synapses in the rat visual cortex. Neurosci. Lett. 309, 117–120.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Naughton, M., Mulrooney, J. B., and Leonard, B. E. (2000). A review of the role of serotonin receptors in psychiatric disorders. Hum. Psychopharmacol. 15, 397–415.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Oberlaender, M., Boudewijns, Z. S., Kleele, T., Mansvelder, H. D., Sakmann, B., and De Kock, C. P. (2011). Three-dimensional axon morphologies of individual layer 5 neurons indicate cell type-specific intracortical pathways for whisker motion and touch. Proc. Natl. Acad. Sci. U.S.A. 108, 4188–4193.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Otsuka, T., and Kawaguchi, Y. (2011). Cell diversity and connection specificity between callosal projection neurons in the frontal cortex. J. Neurosci. 31, 3862–3870.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Paxinos, G., and Franklin, K. B. J. (2004). The Mouse Brain in Stereotaxic Coordinates. San Diego, CA: Elsevier Academic Press.

Pazos, A., Cortes, R., and Palacios, J. M. (1985). Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res. 346, 231–249.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Puig, M. V., Artigas, F., and Celada, P. (2005). Modulation of the activity of pyramidal neurons in rat prefrontal cortex by raphe stimulation in vivo: involvement of serotonin and GABA. Cereb. Cortex 15, 1–14.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Puig, M. V., Santana, N., Celada, P., Mengod, G., and Artigas, F. (2004). In vivo excitation of GABA interneurons in the medial prefrontal cortex through 5-HT3 receptors. Cereb. Cortex 14, 1365–1375.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Puig, M. V., Watakabe, A., Ushimaru, M., Yamamori, T., and Kawaguchi, Y. (2010). Serotonin modulates fast-spiking interneuron and synchronous activity in the rat prefrontal cortex through 5-HT1A and 5-HT2A receptors. J. Neurosci. 30, 2211–2222.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Santana, N., Bortolozzi, A., Serrats, J., Mengod, G., and Artigas, F. (2004). Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cereb. Cortex 14, 1100–1109.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Spain, W. J. (1994). Serotonin has different effects on two classes of Betz cells from the cat. J. Neurophysiol. 72, 1925–1937.

Pubmed Abstract | Pubmed Full Text

Sugino, K., Hempel, C. M., Miller, M. N., Hattox, A. M., Shapiro, P., Wu, C., Huang, Z. J., and Nelson, S. B. (2006). Molecular taxonomy of major neuronal classes in the adult mouse forebrain. Nat. Neurosci. 9, 99–107.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Tanaka, E., and North, R. A. (1993). Actions of 5-hydroxytryptamine on neurons of the rat cingulate cortex. J. Neurophysiol. 69, 1749–1757.

Pubmed Abstract | Pubmed Full Text

Torres-Escalante, J. L., Barral, J. A., Ibarra-Villa, M. D., Perez-Burgos, A., Gongora-Alfaro, J. L., and Pineda, J. C. (2004). 5-HT1A, 5-HT2, and GABAB receptors interact to modulate neurotransmitter release probability in layer 2/3 somatosensory rat cortex as evaluated by the paired pulse protocol. J. Neurosci. Res. 78, 268–278.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Troca-Marin, J. A., and Geijo-Barrientos, E. (2010). Inhibition by 5-HT of the synaptic responses evoked by callosal fibers on cortical neurons in the mouse. Pflugers Arch. 460, 1073–1085.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Weber, E. T., and Andrade, R. (2010). Htr2a Gene and 5-HT(2A) Receptor Expression in the Cerebral Cortex Studied Using Genetically Modified Mice. Front. Neurosci. 4:36. doi: 10.3389/fnins.2010.00036

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Williams, G. V., Rao, S. G., and Goldman-Rakic, P. S. (2002). The physiological role of 5-HT2A receptors in working memory. J. Neurosci. 22, 2843–2854.

Pubmed Abstract | Pubmed Full Text

Willins, D. L., and Meltzer, H. Y. (1997). Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats. J. Pharmacol. Exp. Ther. 282, 699–706.

Pubmed Abstract | Pubmed Full Text

Xiang, Z., and Prince, D. A. (2003). Heterogeneous actions of serotonin on interneurons in rat visual cortex. J. Neurophysiol. 89, 1278–1287.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Yuen, E. Y., Jiang, Q., Chen, P., Feng, J., and Yan, Z. (2008). Activation of 5-HT2A/C receptors counteracts 5-HT1A regulation of n-methyl-D-aspartate receptor channels in pyramidal neurons of prefrontal cortex. J. Biol. Chem. 283, 17194–17204.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Zhang, Z. W. (2003). Serotonin induces tonic firing in layer V pyramidal neurons of rat prefrontal cortex during postnatal development. J. Neurosci. 23, 3373–3384.

Pubmed Abstract | Pubmed Full Text

Zhang, Z. W., and Arsenault, D. (2005). Gain modulation by serotonin in pyramidal neurones of the rat prefrontal cortex. J. Physiol. 566, 379–394.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Zhong, P., Liu, W., Gu, Z., and Yan, Z. (2008a). Serotonin facilitates long-term depression induction in prefrontal cortex via p38 MAPK/Rab5-mediated enhancement of AMPA receptor internalization. J. Physiol. 586, 4465–4479.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Zhong, P., and Yan, Z. (2011). Differential regulation of the excitability of prefrontal cortical fast-spiking interneurons and pyramidal neurons by serotonin and fluoxetine. PLoS One 6:e16970. doi: 10.1371/journal.pone.0016970

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Zhong, P., Yuen, E. Y., and Yan, Z. (2008b). Modulation of neuronal excitability by serotonin-NMDA interactions in prefrontal cortex. Mol. Cell. Neurosci. 38, 290–299.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Zhou, F. M., and Hablitz, J. J. (1999). Activation of serotonin receptors modulates synaptic transmission in rat cerebral cortex. J. Neurophysiol. 82, 2989–2999.

Pubmed Abstract | Pubmed Full Text

Keywords: neocortex, cerebral cortex, serotonin, 5-HT1A receptor, 5-HT2A receptor, pyramidal neuron, corpus callosum, retrograde labeling

Citation: Avesar D and Gulledge AT (2012) Selective serotonergic excitation of callosal projection neurons. Front. Neural Circuits 6:12. doi: 10.3389/fncir.2012.00012

Received: 04 February 2012; Paper pending published: 28 February 2012;
Accepted: 28 February 2012; Published online: 20 March 2012.

Edited by:

Yoshiyuki Kubota, National Institute for Physiological Sciences, Japan

Reviewed by:

Daniel Johnston, University of Texas, USA
Bob C. Foehring, University of Tennessee, USA

Copyright: © 2012 Avesar and Gulledge. This is an open-access article distributed under the terms of the Creative Commons Attribution Non Commercial License, which permits non-commercial use, distribution, and reproduction in other forums, provided the original authors and source are credited.

*Correspondence: Allan T. Gulledge, Department of Physiology and Neurobiology, Dartmouth Medical School, One Medical Center Drive, DHMC, Borwell 704E, Lebanon 03756, NH, USA. e-mail: allan.gulledge@dartmouth.edu

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.